National Institute of Health

Go to main contents

Pilot Project for the Establishment of
the National Integrated Bio Big Data 2020 to 2022

The pilot project is a citizen participatory platform that aims to ensure healthy
life for the next generation. For healthy life, [I, we and the Republic of Korea] participate(s).
It is a participatory project that collects clinical and genetic information necessary
for research from Koreans. The project is the most historical fundamental and
meaningful movement of health data collection in the Korean medical history.

Establishment of Healthcare-Medical
Research Data Center

The National Institute of Health, The era where big data of healthcare research
resources is open assess or controlled access. The national future medical
research leads a new era for identifying a cause of disease!

In the era of BIO BIGDATA, the National Institute of Health provides a platform
where researchers can use secured and open resources for research on the
health of people and bio health at the “Healthcare-Medical Research Data Center”.

Discussing the challenges and future of
Korea's space medicine research
in the age of space development.

The Korea National Institute of Health is planning the Space Medicine Research
Platform Building Project to improve people's health and gain competitveness
in the bio health industry in the coming age of space.

International cooperation

Participate in efforts to overcome COVID…

Statens Serum Institut

Statens Serum Institut of Denmark (SSI)

Strengthening mutual cooperation for sharing vaccine production information, including each institution’s roles in vaccine development, vaccine development and progress in research, and cross-vaccination issues, in order to ensure safe and effective development and supply of COVID-19 vaccines

Participate in efforts to overcome COVID…

U.S. National Institute of Allergy and Infectious Diseases

U.S. National Institute of Allergy and Infectious Diseases (NIAID)

- Exchanging expression of interest (EOI) letters for research cooperation in vaccines and medications
- Prioritizing research in vaccine development and medications for new infectious diseases, including COVID-19
- Planning to conduct research on vaccines and medications for tuberculosis, antibiotic resistance, and immunology of infectious diseases.

Participate in efforts to overcome COVID…

U.S. Moderna

U.S. Moderna

mRNA vaccine research cooperation for COVID-19 and infectious diseases of mutual interest

Participate in efforts to overcome COVID…

UN International Vaccine Institute

UN International Vaccine Institute (IVI)

Creating synergies through mutual cooperation for vaccine research

Participate in efforts to overcome COVID…

Leibniz Institute DSMZ - Deutsche Sammlung von Mikroorganismen und Zellkulturen

Leibniz Institute DSMZ - Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)

Building an organic network for the exchange and research of microbial resources, including pathogens

What We do

Advanced regenerative medical safety management

The Korea National Institute of Health provides support to ensure the safety of research subjects of advanced regenerative medicine clinical research and to facilitate clinical research.
Article 19 of the Act on the Safety of and Support for Advanced Regenerative Medicine and Advanced Biological Products

National Institute of Infectious Diseases

As the control tower for national infectious disease research to secure “vaccine sovereignty,” we develop measures and produce scientific evidence for the prevention of and prompt response to infectious diseases. We investigate not only emerging and variant infectious diseases but also unresolved infectious diseases, vectors, and drug resistance, and conduct diverse clinical trials.

Korea National Stem Cell Bank

Korea National Stem Cell Bank (KSCB) is a biorepository of the human pluripotent stem cell lines. To be the world`s leading class as an infrastructure supporting regenerative medicine, the bank provides the high quality stem cells and related information for regenerative medicine. The bank will compliance with standards of bioethics and safety regulations.

The GMP Manufacturing facility

The GMP Manufacturing facility which is belonged to the National Center for Stem Cell and Regerative Medicine (NCSR) was opened in 2016 to accelerate clinical research of the stem cell and regenerative medicine field. In addition to manufacturing and distribution of iPSC sources that can be used for clinical research, we support manufacture of cell therapeutics for clinical research. Recently, by starting a GMP training course for manufacture of advanced regenerative therapeutics, we expect that the GMP market will be facilitated.

National Brain Biobank of Korea (NBBK)

The National Brain Biobank of Korea is being established to collect advanced brain and human body resources with antemortem clinical data, such as brain imaging scans, and postmortem pathological information and provide them to basic and clinical researchers to activate Korea’s dementia research.

Inside Labs

Up to Scratch: Testing a Promising Anti-Itch Topical Medication

Caring for the Ones Who Care: Mental Health of Korean Nurses During COVID-19

Monoclonal Antibody CT-P59: Another Silver Bullet Against Novel Coronavirus

Harnessing the Power of Genomics for Early Prediction of Type 2 Diabetes in East Asians

Database

Who We Are

Director of the Korea National Institute of Health - Kwon Joon-wook

Director of the Korea National Institute of Health

I thank you for visiting the Korea National Institute of Health website. The Korea National Institute of Health is a leading medical science research institute in Korea. It is on the cutting edge of research in key areas, including infectious and chronic…

NIH in Media